Investigational Drug Study for Children and Adults with Autism Spectrum Disorders


What are we studying?

The purpose of this study is to evaluate whether an investigational drug is safe and effective for the treatment of the symptoms of Autism Spectrum Disorders.

Who can participate?

Participants in this questionnaire based study must meet specific eligibility criteria including:

  • Males and females between 5 and 21 years of age
  • Who have a diagnosis of Autism Spectrum Disorder
  • Who exhibit behaviors such as being listless, sluggish, or inactive, isolates themselves from others, has fixed expressions or lack of emotions

How will participants be compensated?

  • Participants will be compensated for travel
  • The investigation drug is free of charge and all study-related evaluations are free of charge

Docket # 14230; 209AS208

A PDF brochure is available for this study.


LogoInvesting in the future...helping kids and families.